Tag Archives: Ed Markey

‘The Dam Is Breaking,’ Declare Net Neutrality Defenders After First House Republican Backs CRA

“We urge Congressman Coffman’s Republican colleagues to follow his lead and sign the discharge petition to restore net neutrality. It’s the right thing to do.”

By Jessica Corbett, staff writer for Common Dreams. Published 7-17-2017

Net neutrality advocates rallied outside the Lincoln, Nebraska office of Rep. Jeff Fortenberry (R-Neb.) on July 13, 2018 to urge him to support a measure that would restore net neutrality protections nationwide. (Photo: @IndivisibleLNK/Twitter)

“The dam is breaking, as it should.”

That’s how Faiz Shakir, the ACLU’s national political director, responded on Tuesday after Rep. Mike Coffman of Colorado became the first House Republican to sign a petition to force a vote on a measure that would reinstate net neutrality protections that the GOP-controlled Federal Communications Commission (FCC) rolled back in December.

“Rep. Coffman’s support to undo FCC Chairman Ajit Pai’s repeal of net neutrality shows that public pressure is continuing to build on this issue and cannot be ignored this November,” Shakir added. “Other House members should take heed of Coffman’s direction and stand by the overwhelming majority of their constituents, not corporate interests.” Continue reading

Share

Insiders Admit Trump’s EPA Burying Cancer-Causing Chemical Study Unfriendly to Industry

New reporting in Politico adds further weight to claims of suppression of report on formaldehyde

By Andrea Germanos, staff writer for Common Dreams. Published 7-7-2018

Photo: Pinterest

New reporting in Politico puts the spotlight on continued themes of the Trump administration: suppression of science, threats to public health, and carrying out the bidding of industry. The issue laid out involves alleged political interference at the Environmental Protection Agency, and while the agency’s current administrator, scandal-riddled Scott Pruitt, is now on his way out the door, the reins now head to number two Andrew Wheeler, who offers little reason to believe the burying of a key report will soon end.

As Politico‘s Annie Snider reported, Trump appointees at the agency are blocking the release of an assessment on formaldehyde produced by the EPA’s Integrated Risk Information System (IRIS). A draft assessment already completed confirms research linking the common chemical to leukemia, nose and throat cancer, and other adverse health effects. Continue reading

Share

Urgent Demands for Congress to Act as Net Neutrality’s “Slow and Insidious” Death Begins

“Momentum is on our side, but time isn’t. Members of Congress need to know that there will be a price to pay for being on the wrong side of internet history.”

By Jake Johnson, staff writer for Common Dreams. Published 4-23-2018

Protest for net neutrality in New York City in December 2017. Photo: Mark Stanley/Twitter

Today is the day that net neutrality’s “slow and insidious” death at the hands of the Republican-controlled FCC officially begins, and Congress is facing urgent pressure to save the open internet before it’s too late.

With Monday marking 60 days after the FCC’s net neutrality repeal entered the Federal Register, parts of the GOP-crafted plan—spearheaded by agency chair and former Verizon lawyer Ajit Pai—will now slowly begin taking effect, while some still need to be approved by the Office of Management and Budget. Continue reading

Share

Sanders Puts Block on Obama’s Big Pharma Nominee for FDA

‘We need someone who will work to substantially lower drug prices, implement rules to safely import brand-name drugs from Canada and hold companies accountable who defraud our government.’

By Nadia Prupis, staff writer for Common Dreams. Published 1-26-2016

Bernie Sanders joined two other senators in blocking Obama's nomination for FDA chief. (Photo: Gage Skidmore/flickr/cc)

Bernie Sanders joined two other senators in blocking Obama’s nomination for FDA chief. (Photo: Gage Skidmore/flickr/cc)

Senator Bernie Sanders put a hold on President Barack Obama’s nominee to take over the Food and Drug Administration (FDA) on Tuesday, joining with two other senators who have also objected to Dr. Robert M. Califf’s nomination, citing his ties to corporate drug manufacturers.

“Dr. Califf’s extensive ties to the pharmaceutical industry give me no reason to believe that he would make the FDA work for ordinary Americans, rather than just the CEOs of pharmaceutical companies,” Sanders said in a statement on Tuesday. “We need someone who will work to substantially lower drug prices, implement rules to safely import brand-name drugs from Canada and hold companies accountable who defraud our government.” Continue reading

Share